Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells

Recently discovered broadly neutralizing antibodies (bNAbs) against HIV-1 demonstrate extensive breadth and potency against diverse HIV-1 strains and represent a promising approach for the treatment and prevention of HIV-1 infection. The breadth and potency of these antibodies have primarily been ev...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Virol
Auteurs principaux: Cohen, Yehuda Z., Lorenzi, Julio C. C., Seaman, Michael S., Nogueira, Lilian, Schoofs, Till, Krassnig, Lisa, Butler, Allison, Millard, Katrina, Fitzsimons, Tomas, Daniell, Xiaoju, Dizon, Juan P., Shimeliovich, Irina, Montefiori, David C., Caskey, Marina, Nussenzweig, Michel C.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2018
Sujets:
Vaccines and Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5809738/
https://ncbi.nlm.nih.gov/pubmed/29237833
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01883-17
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires